iRhythm Technologies logo
iRhythm Technologies
IRTC | NASDAQ
Chart Builder DCF Calculator
$90.83
-$1.08 (-1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$90.83
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

iRhythm Technologies Company Profile

Company profile explained

Company Profile

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

Key Executives

Name Position
Quentin S. Blackford President, Chief Executive Officer & Director
Brian Lawrence Executive Vice President & Chief Technology Officer
Daniel G. Wilson Chief Financial Officer & Principal Financial Officer
Chad Patterson Chief Commercial and Product Officer
Lisa Pecora Senior Vice President of Finance & Investor Relations
Marc Rosenbaum Senior Vice President of Finance & Chief Accounting Officer
Mervin Smith Executive Vice President of Business Operations
Minang Turakhia Chief Medical & Scientific Officer and Executive Vice President of Advanced Technologies
Patrick Michael Murphy Chief Business & Legal Officer
Sean Clinton Freeman Executive Vice President of Strategy & Corporate Development

Latest SEC Filings

Date Type Title
Oct 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 05, 2026 8-K Current Report
Sep 22, 2026 8-K Current Report
Sep 03, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 13, 2026 8-K Current Report
Aug 11, 2026 4 Filing
Aug 11, 2026 4 Filing
Aug 11, 2026 4 Filing
View All SEC Filings ➞
iRhythm Technologies
iRhythm Technologies logo
Country United States
IPO Date Oct 20, 2016
Industry Medical - Devices
Sector Healthcare
Employees 2,400
CEO Quentin S. Blackford

Contact Details

699 8th Street San Francisco, California 94103 United States

Stock Details

Ticker Symbol IRTC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001388658
CUSIP Number 450056106
ISIN Number US4500561067
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.